Doctor profile · Federal record
Dr. PARAG DESAI, M.D.
Internal Medicine Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · Pulmonary Disease Physician · PHILADELPHIA, PA
- NPI 1205089976
- Accepts Medicare
- MIPS 72.5 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3401 N BROAD ST
PHILADELPHIA, PA 191405103
(215) 707-5864
fax (215) 707-6867 - Mailing address
-
2450 W HUNTING PARK AVE
PHILADELPHIA, PA 191291302
Credentials & registration
- NPI registered
- October 2008 — 18 yrs on file
- Profile last updated
- April 18, 2018
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Pennsylvania #MD434073
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1205089976. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
661
Distinct HCPCS
10
Medicare allowed
$72,047
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 183 | 70 | $223 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 96 | 62 | $102 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 69 | 34 | $135 | |
94010 |
Test to measure expiratory airflow and volume | 66 | 60 | $8 | |
94618 |
Test for exercise-induced lung stress | 52 | 52 | $23 | |
94729 |
Test to examine how well the lungs exchange gases | 48 | 48 | $9 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 34 | 18 | $124 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 32 | 19 | $83 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 29 | 29 | $11 | |
94726 |
Test to determine lung volumes using sensors | 26 | 26 | $12 |
In context: peer comparison
Among 390 peers in this city , average services per provider: 132. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$47
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $24.79 | |
| Tactile Systems Technology Inc | 1 | $21.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
967
Patients
219
Total drug cost
$1,626,805
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 169 | 33 | $135,842 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 103 | 23 | $3,948 |
| Azithromycin | Generic | 96 | 39 | $4,044 |
| Prednisone | Generic | 88 | 53 | $560 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 83 | 21 | $35,596 |
| Ofev (Nintedanib Esylate) | Brand | 68 | 0 | $890,947 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 67 | 14 | $24,890 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 59 | 13 | $27,645 |
| Fluticasone Propionate | Generic | 44 | 12 | $866 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 41 | 0 | $22,087 |